Skip to content

ONWARD Medical N.V.

LEI 9845007A2CC4C8BFSB80Netherlandsfmd_0TY17CEZX41PFWCEF88GJ1R5NBTemplate: Standard

This company files annual reports on an EU or UK regulated market, not with the SEC. Statements come from its ESEF annual report in EUR and are not converted. Ownership, prices, dividends and events are built from SEC and US market data and are not available for it.

Coverage: Jan 01, 2021 to Dec 31, 2025, 5 periods

Latest annual · FY2025

Millions
Total revenues
5
Gross profit
4
Operating income
(41)
Net income
(42)
Free cash flow
(39)

Bulls and bears

Loading

News summary

An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.

AI-written
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2022 to FY2025
n/m

ONWARD Medical N.V. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2025FY2024ChangeSource
Revenue€5.4 million€1.7 million+211.3%AFR 2026-03-31 · proof
Gross profit€4.4 million€1.7 million+154.8%AFR 2026-03-31 · proof
Operating income-€40.9 million-€34.9 millionAFR 2026-03-31 · proof
Net income-€41.8 million-€35.7 millionAFR 2026-03-31 · proof
Cash from operating activities-€39.1 million-€31.8 millionAFR 2026-03-31 · proof
Free cash flow-€39.5 million-€31.9 millionAFR 2026-03-31 · proof
Total assets€84.6 million€76.1 million+11.1%AFR 2026-03-31 · proof
Cash and cash equivalents€68.1 million€60 million+13.4%AFR 2026-03-31 · proof
What was ONWARD Medical N.V.'s revenue in fiscal 2025?
ONWARD Medical N.V. reported revenue of €5.4 million for fiscal 2025 (the year ended Dec 31, 2025), against €1.7 million the year before (+211.3%). Source: the AFR filed with the SEC on Mar 31, 2026. SEC
What was ONWARD Medical N.V.'s gross profit in fiscal 2025?
ONWARD Medical N.V. reported gross profit of €4.4 million for fiscal 2025 (the year ended Dec 31, 2025), against €1.7 million the year before (+154.8%). Source: the AFR filed with the SEC on Mar 31, 2026. SEC
What was ONWARD Medical N.V.'s operating income in fiscal 2025?
ONWARD Medical N.V. reported operating income of -€40.9 million for fiscal 2025 (the year ended Dec 31, 2025), against -€34.9 million the year before. Source: the AFR filed with the SEC on Mar 31, 2026. SEC
What was ONWARD Medical N.V.'s net income in fiscal 2025?
ONWARD Medical N.V. reported net income of -€41.8 million for fiscal 2025 (the year ended Dec 31, 2025), against -€35.7 million the year before. Source: the AFR filed with the SEC on Mar 31, 2026. SEC
What was ONWARD Medical N.V.'s cash from operating activities in fiscal 2025?
ONWARD Medical N.V. reported cash from operating activities of -€39.1 million for fiscal 2025 (the year ended Dec 31, 2025), against -€31.8 million the year before. Source: the AFR filed with the SEC on Mar 31, 2026. SEC
What was ONWARD Medical N.V.'s free cash flow in fiscal 2025?
ONWARD Medical N.V. reported free cash flow of -€39.5 million for fiscal 2025 (the year ended Dec 31, 2025), against -€31.9 million the year before. Source: the AFR filed with the SEC on Mar 31, 2026. SEC
What are ONWARD Medical N.V.'s total assets?
As of Dec 31, 2025, ONWARD Medical N.V. reported total assets of €84.6 million, against €76.1 million a year earlier (+11.1%). Source: the AFR filed with the SEC on Mar 31, 2026. SEC
What are ONWARD Medical N.V.'s cash and cash equivalents?
As of Dec 31, 2025, ONWARD Medical N.V. reported cash and cash equivalents of €68.1 million, against €60 million a year earlier (+13.4%). Source: the AFR filed with the SEC on Mar 31, 2026. SEC

Read from the FinancialMD API on Nov 19, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=fmd_0TY17CEZX41PFWCEF88GJ1R5NB&period_type=annual&limit=5"

Information only, not investment advice.